Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action.
Mol Cancer
; 14: 199, 2015 Nov 21.
Article
in En
| MEDLINE
| ID: mdl-26588899
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Transcription, Genetic
/
Carcinoma, Pancreatic Ductal
/
Transforming Growth Factor beta1
/
Dasatinib
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Mol Cancer
Journal subject:
NEOPLASIAS
Year:
2015
Type:
Article
Affiliation country:
Germany